Competition authority green lights Al Hammadi’s acquisition of 35% stake in Sudair Pharma

10/10/2021 Argaam

Logo of General Authority for Competition (GAC)

The General Authority for Competition (GAC) approved Al Hammadi Company for Development and Investment’s acquisition of a 35% stake in Sudair Pharmaceutical Company (SPC), the company said in a bourse filing.
 

Last July, the Tadawul-listed company signed an agreement to acquire Gulf Investment Corporation’s (GIC) 35% stake in Sudair Pharmaceutical, Argaam earlier reported.

Comments {{getCommentCount()}}

Be the first to comment

{{comment.FollowersCount}}
{{comment.CommenterComments}}

رد{{comment.DisplayName}} على {{getCommenterName(comment.ParentThreadID)}}

{{comment.DisplayName}} حساب موثّق

{{comment.ElapsedTime}}
{{comment.Replies.length}}
تعديل
loader Train
Report
loader Train
Sorry: the validity period has ended to comment on this news
Opinions expressed in the comments section do not reflect the views of Argaam. Abusive comments of any kind will be removed. Political or religious commentary will not be tolerated.